透明质酸填充剂注射后延迟栓塞所致剧痛的成功处理 - Suppr | 超能文献

文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

透明质酸填充剂注射后延迟栓塞所致剧痛的成功处理 - Suppr | 超能文献

Successful management of extreme pain from delayed embolization after hyaluronic acid filler injection.

作者信息

Rullan Peter P, Lee Kachiu C

机构信息

Clinical Faculty, Department of Dermatology, University of California San Diego, San Diego, California.

Dermatology Institute, Chula Vista, California.

出版信息

JAAD Case Rep. 2019 Jun 26;5(7):569-571. doi: 10.1016/j.jdcr.2019.04.003. eCollection 2019 Jul.

DOI:10.1016/j.jdcr.2019.04.003

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6610638/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3590/6610638/84ba04285c6f/gr3.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3590/6610638/d05ce670cd52/gr1.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3590/6610638/d5c66d0e62f2/gr2.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3590/6610638/84ba04285c6f/gr3.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3590/6610638/d05ce670cd52/gr1.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3590/6610638/d5c66d0e62f2/gr2.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3590/6610638/84ba04285c6f/gr3.jpg

相似文献

1

Successful management of extreme pain from delayed embolization after hyaluronic acid filler injection.透明质酸填充剂注射后延迟栓塞所致剧痛的成功处理

JAAD Case Rep. 2019 Jun 26;5(7):569-571. doi: 10.1016/j.jdcr.2019.04.003. eCollection 2019 Jul.

2

Temporal fossa defects: techniques for injecting hyaluronic acid filler and complications after hyaluronic acid filler injection.颞部凹陷：透明质酸填充剂注射技术及注射后的并发症

J Cosmet Dermatol. 2015 Sep;14(3):254-9. doi: 10.1111/jocd.12155. Epub 2015 Jul 16.

3

Ischemic oculomotor nerve palsy and skin necrosis caused by vascular embolization after hyaluronic acid filler injection: a case report.透明质酸填充剂注射后血管栓塞导致的缺血性动眼神经麻痹和皮肤坏死：一例报告

Ann Plast Surg. 2013 Oct;71(4):333-4. doi: 10.1097/SAP.0b013e31824f21da.

4

A split-face comparison of a new hyaluronic acid facial filler containing pre-incorporated lidocaine versus a standard hyaluronic acid facial filler in the treatment of naso-labial folds.含预混利多卡因的新型透明质酸面部填充剂与标准透明质酸面部填充剂治疗鼻唇沟的半脸对照研究。

J Cosmet Laser Ther. 2009 Sep;11(3):169-73. doi: 10.1080/14764170902833142.

5

Delayed hypersensitivity reaction to hyaluronic acid dermal filler following influenza-like illness.流感样疾病后对透明质酸真皮填充剂的迟发型超敏反应

Clin Cosmet Investig Dermatol. 2019 Apr 29;12:277-283. doi: 10.2147/CCID.S198081. eCollection 2019.

6

Severe vision loss caused by cosmetic filler augmentation: Case series with review of cause and therapy.美容填充剂注射导致的严重视力丧失：病例系列及病因与治疗综述

J Cosmet Dermatol. 2018 Oct;17(5):712-718. doi: 10.1111/jocd.12705. Epub 2018 Jul 13.

7

The duration of hyaluronidase and optimal timing of hyaluronic acid (HA) filler reinjection after hyaluronidase injection.透明质酸酶的作用持续时间以及透明质酸酶注射后透明质酸（HA）填充剂再次注射的最佳时机。

J Cosmet Laser Ther. 2018 Feb;20(1):52-57. doi: 10.1080/14764172.2017.1293825. Epub 2017 Dec 4.

8

Successful hyaluronic acid filler injection in a chronic myeloid leukemia patient taking imatinib mesylate.在一名服用甲磺酸伊马替尼的慢性髓性白血病患者中成功进行透明质酸填充剂注射。

J Cosmet Laser Ther. 2019;21(4):243-244. doi: 10.1080/14764172.2018.1525745. Epub 2018 Oct 4.

9

A Comparison of the Efficacy and Safety Between Hyaluronic Acid and Polylactic Acid Filler Injection in Penile Augmentation: A Multicenter, Patient/Evaluator-Blinded, Randomized Trial.透明质酸与聚左旋乳酸填充物注射阴茎增大术的疗效和安全性比较：一项多中心、患者/评估者双盲、随机试验。

J Sex Med. 2019 Apr;16(4):577-585. doi: 10.1016/j.jsxm.2019.01.310. Epub 2019 Mar 2.

10

Ultrasound to improve the safety of hyaluronic acid filler treatments.超声检查可提高透明质酸填充治疗的安全性。

J Cosmet Dermatol. 2018 Dec;17(6):1019-1024. doi: 10.1111/jocd.12726. Epub 2018 Aug 6.

本文引用的文献

1

Update on Avoiding and Treating Blindness From Fillers: A Recent Review of the World Literature.避免和治疗填充物引起失明的最新进展：世界文献的最新回顾。

Aesthet Surg J. 2019 May 16;39(6):662-674. doi: 10.1093/asj/sjz053.

2

Experience and Management of Intravascular Injection with Facial Fillers: Results of a Multinational Survey of Experienced Injectors.面部填充剂血管内注射的经验与管理：一项针对经验丰富注射者的多国调查结果

Aesthetic Plast Surg. 2016 Aug;40(4):549-55. doi: 10.1007/s00266-016-0658-1. Epub 2016 Jun 10.

3

Clinical Outcomes of Impending Nasal Skin Necrosis Related to Nose and Nasolabial Fold Augmentation with Hyaluronic Acid Fillers.

与使用透明质酸填充剂进行鼻部及鼻唇沟填充相关的即将发生的鼻皮肤坏死的临床结局

Plast Reconstr Surg. 2015 Oct;136(4):434e-441e. doi: 10.1097/PRS.0000000000001579.

4

Avoiding and Treating Blindness From Fillers: A Review of the World Literature.避免和治疗填充剂导致的失明：世界文献综述

Dermatol Surg. 2015 Oct;41(10):1097-117. doi: 10.1097/DSS.0000000000000486.

5

Treatment of Hyaluronic Acid Filler-Induced Impending Necrosis With Hyaluronidase: Consensus Recommendations.用透明质酸酶治疗透明质酸填充剂引起的即将发生的坏死：共识建议。

Aesthet Surg J. 2015 Sep;35(7):844-9. doi: 10.1093/asj/sjv018. Epub 2015 May 10.

6

Reticulated erythema after nasolabial fold injection with hyaluronic acid: the importance of immediate attention.

Dermatol Surg. 2011 Nov;37(11):1697-9. doi: 10.1111/j.1524-4725.2011.02098.x. Epub 2011 Aug 1.

7

Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase.透明质酸注射栓子后即将发生坏死的一种罕见表现的成功处理及用透明质酸酶处理的建议方案

Dermatol Surg. 2007 Mar;33(3):357-60. doi: 10.1111/j.1524-4725.2007.33073.x.

8

Ropivacaine 0.2% and lidocaine 0.5% for intravenous regional anesthesia in outpatient surgery.0.2%罗哌卡因和0.5%利多卡因用于门诊手术的静脉区域麻醉。

Anesthesiology. 2001 Sep;95(3):627-31. doi: 10.1097/00000542-200109000-00013.

9

Comparison of ropivacaine and lidocaine for intravenous regional anesthesia in volunteers: a preliminary study on anesthetic efficacy and blood level.志愿者中罗哌卡因与利多卡因用于静脉区域麻醉的比较：关于麻醉效果和血药浓度的初步研究

Anesthesiology. 1999 Jun;90(6):1602-8. doi: 10.1097/00000542-199906000-00016.